Jason Keyes
No más puestos en curso
Fortuna: 315 622 $ al 31/03/2024
Historial de carrera de Jason Keyes
Antiguos cargos conocidos de Jason Keyes.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| EQUILLIUM, INC. | Director of Finance/CFO | 01/03/2018 | 06/03/2024 |
| CARISMA THERAPEUTICS, INC. | Director/Board Member | 20/02/2020 | 07/03/2023 |
| Independent Dir/Board Member | 20/02/2020 | 07/03/2023 | |
| OREXIGEN THERAPEUTICS, INC. | Director of Finance/CFO | 01/02/2015 | 23/02/2018 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Director of Finance/CFO | 01/08/2007 | 01/01/2013 |
Formación de Jason Keyes.
| Stanford University | Graduate Degree |
| University of California, Los Angeles | Masters Business Admin |
| UCLA Anderson School of Management | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 8 |
Operativa
| Director of Finance/CFO | 3 |
| Masters Business Admin | 2 |
| Graduate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| EQUILLIUM, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Jason Keyes
- Experiencia
